We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ONCT market cap is 1.98M. The company's latest EPS is USD -13.3391 and P/E is -0.06.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 106k | 179k | 297k | 569k | 801k |
| Operating Income | -9.55M | -10.39M | -9.64M | -8.78M | -8.86M |
| Net Income | -8.97M | -9.86M | -9.16M | -8.39M | -8.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.43M | 3.38M | 4.32M | 1.49M | 785k |
| Operating Income | -33.11M | -17.54M | -31.37M | -44.95M | -41.71M |
| Net Income | -34.19M | -17.23M | -31.33M | -44.17M | -39.48M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50.77M | 43.2M | 36.73M | 29.14M | 23.86M |
| Total Liabilities | 5.59M | 6.2M | 6.68M | 6.22M | 8.11M |
| Total Equity | 45.18M | 37M | 30.05M | 22.93M | 15.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.74M | 118.81M | 93.59M | 68.65M | 36.73M |
| Total Liabilities | 7.43M | 5.86M | 5.47M | 7.68M | 6.68M |
| Total Equity | 14.31M | 112.95M | 88.12M | 60.97M | 30.05M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.23M | -25.75M | -32.16M | -7.44M | -13.26M |
| Investing | -2.2M | 2.46M | 651k | 7.22M | 13.03M |
| Financing | 1.12M | 1.07M | 1.07M | -87k | -87k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.75M | -17.5M | -26.59M | -36.7M | -32.16M |
| Investing | 16.14M | N/A | N/A | -26.5M | 651k |
| Financing | 15k | 114.18M | 617k | 9.58M | 1.07M |
| Market Cap | 1.98M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 2.94 |
| Price to Cash Ratio | 0.34 |
| Price to Book Ratio | 0.08 |
| Dividend Yield | - |
| Shares Outstanding | 2.96M |
| Average Volume (1 week) | 32.59k |
| Average Volume (1 Month) | 85.28k |
| 52 Week Change | -90.18% |
| 52 Week High | 13.14 |
| 52 Week Low | 1.03 |
| Spread (Intraday) | 0.01 (1.02%) |
| Company Name | Oncternal Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.oncternal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
